Novo Nordisk earnings preview: Q1 miss, guidance cut in focus as obesity drug demand cools By Investing.com
- Posted on May 7, 2025
- By Investing.com
- 4 Views
Novo Nordisk earnings preview: Q1 miss, guidance cut in focus as obesity drug demand cools By Investing.com
Novo Nordisk earnings preview: Q1 miss, guidance cut in focus as obesity drug demand cools
